AP
ORCL icon

Antipodes Partners’s Oracle ORCL Stock Holding History

Antipodes Partners’s Portfolio ORCL Stock Details ORCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-212,117
Closed -$31.2M – 146
2026
Q1 		$31.2M Sell
212,117
-27,574
-12% -$4.48M 0.6% 46
2025
Q4 		$46.7M Buy
+239,691
New +$57.1M 0.98% 37
2025
Q2 		– Sell
-282,070
Closed -$39.4M – 119
2025
Q1 		$39.4M Sell
282,070
-235,923
-46% -$38.4M 1.24% 27
2024
Q4 		$86.3M Sell
517,993
-396,159
-43% -$70.4M 3% 14
2024
Q3 		$156M Sell
914,152
-337,908
-27% -$48.9M 5.4% 4
2024
Q2 		$177M Sell
1,252,060
-387,827
-24% -$48.2M 6.42% 2
2024
Q1 		$206M Sell
1,639,887
-23,331
-1% -$2.67M 6.52% 2
2023
Q4 		$175M Sell
1,663,218
-39,058
-2% -$4.26M 5.48% 2
2023
Q3 		$181M Buy
1,702,276
+170,203
+11% +$19.7M 5.81% 2
2023
Q2 		$182M Sell
1,532,073
-385,287
-20% -$39.8M 6.3% 2
2023
Q1 		$178M Sell
1,917,360
-150,950
-7% -$13.2M 6.17% 2
2022
Q4 		$169M Sell
2,068,310
-257,451
-11% -$19.6M 6.06% 3
2022
Q3 		$142M Buy
2,325,761
+43,332
+2% +$3.17M 5.7% 3
2022
Q2 		$159M Buy
2,282,429
+267,049
+13% +$19.5M 6.64% 2
2022
Q1 		$167M Buy
2,015,380
+760,234
+61% +$61.6M 5.91% 6
2021
Q4 		$109M Sell
1,255,146
-92,764
-7% -$8.71M 3.93% 13
2021
Q3 		$117M Buy
1,347,910
+406,909
+43% +$35.9M 4.01% 11
2021
Q2 		$73.2M Buy
+941,001
New +$73.7M 2.64% 18
2019
Q1 		– Sell
-1,953,978
Closed -$88.2M – 29
2018
Q4 		$88.2M Sell
1,953,978
-171,159
-8% -$8.2M 4.36% 11
2018
Q3 		$110M Buy
2,125,137
+280,846
+15% +$13.6M 5.09% 9
2018
Q2 		$81.3M Buy
1,844,291
+75,914
+4% +$3.5M 3.86% 14
2018
Q1 		$80.9M Buy
1,768,377
+449,732
+34% +$22.4M 3.63% 14
2017
Q4 		$62.3M Buy
1,318,645
+198,854
+18% +$9.75M 3.65% 14
2017
Q3 		$53.9M Buy
+1,119,791
New +$55.7M 3.97% 13

Other funds holding ORCL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Antipodes Partners's ORCL Position: Q2 2026 in Review

Antipodes Partners sold out of Oracle (ORCL) in Q2 2026, closing a stake of 212,117 shares — an estimated $31.2M sold.

Antipodes Partners first reported a position in ORCL in Q3 2017 and held it in 24 quarters. The position peaked at $206M in Q1 2024. 3,527 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Antipodes Partners reported no remaining Oracle position as of Q2 2026 after selling out during the quarter.
  • Antipodes Partners sold 212,117 Oracle shares in Q2 2026, an estimated $31.2M.
  • Antipodes Partners first reported a position in Oracle in Q3 2017 and held it in 24 quarters.
  • Antipodes Partners's Oracle position peaked at $206M in Q1 2024.
  • 3,527 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.